Form 8.3 - Primary Health Properties Plc

What specific transaction or event is disclosed in the Form 8.3 filing for Primary Health Properties Plc? What are the financial terms and valuation of the transaction, and how will it affect the company's balance sheet? Will the filing result in any changes to the company's dividend policy or payout ratio? How does this filing impact the company's projected cash flow and earnings guidance for the upcoming quarters? Are there any covenants, regulatory approvals, or contingent considerations that could affect the execution of the disclosed transaction? What is the expected impact of this filing on PH's share price in the short term and over the next 12 months? How does this transaction compare to recent similar deals within the UK REIT or healthcare property sector? Does the filing indicate any strategic shift in Primary Health Properties’ portfolio allocation or geographic focus? What are the potential risks or upside scenarios associated with the disclosed transaction for shareholders? How might this filing influence analyst sentiment and target price revisions for PH?